Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in Wyoming. Pick another state for the same tag.
Against expectation — 2025
Wyoming cites F756 more often than its own record predicts
Versus expected share1.41×
1.41 times the share F756 takes of citations nationally.
Share of Wyoming citations1.12%
Of every deficiency written in Wyoming in 2025, this is the portion that was F756.
Wyoming1.12%
National0.79%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Wyoming surveyors wrote
F756 findings written in Wyoming, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJanuary 23, 2026
Based on medical record review, staff interview, and policy and procedure review, the facility failed to act on pharmacy recommendations for 1 of 6 sample residents (#18) reviewed for unnecessary medications. The findings were:1. Review of a monthly medication regimen review for December 2025 showed the pharmacy recommended discontinuing hydroxyzine 25 mg, taken as needed for anxiety. Further review showed the physician accepted the pharmacy recommendation and ordered hydroxyzine to be discontinued. Review of the physician orders showed the hydroxyzine had not been discontinued. 2.Interview with the DON on 1/23/26 at 8:30 AM confirmed the medication had not been discontinued. 3. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction